Search for
Menu
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Venture Studio
Our Mentors
Rev1 at The Peninsula
Rev1 Labs
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Venture Studio
Our Mentors
Rev1 at The Peninsula
Rev1 Labs
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
Search for
Archives:
Press
Categories
Categories
Filter by Topics
Business
Capital
Getting Customers
Getting Funding
Getting Started
Inclusive Entrepreneurship
Market
Press
Product
Rev1 News
Startup Buzz
Team
The Hard Stuff
Uncategorized
VC Trends
Niobium Raises $23M+ in Oversubscribed Funding to Advance FHE Hardware Acceleration for the Quantum and AI Era
Funding News
12/03/2025
Niobium Raises $23M+ in Oversubscribed Funding to Advance FHE Hardware Acceleration for the Quantum and AI Era
InnerActiv Adds Former Cardinal Health CEO Mike Kaufmann to Board, Former NSA Ops Director Jon Darby as Advisor
Funding News
11/25/2025
InnerActiv Adds Former Cardinal Health CEO Mike Kaufmann to Board, Former NSA Ops Director Jon Darby as Advisor
Rev1 Ventures, Ohio State partner with City of Columbus to create ‘Software Alley’
Rev1 News
11/25/2025
Rev1 Ventures, Ohio State partner with City of Columbus to create ‘Software Alley’
HealthPlan Data Solutions Rebrands as Rivera, Unveiling a Bold New Era of PBM Oversight
Company News
11/10/2025
HealthPlan Data Solutions Rebrands as Rivera, Unveiling a Bold New Era of PBM Oversight
Dublin’s Healthy Roster sells majority stake to PE firm, acquires another software maker
Funding News
11/06/2025
Dublin’s Healthy Roster sells majority stake to PE firm, acquires another software maker
Columbus biopharma company secures $18M for diabetic dry eye treatment trials
Funding News
11/04/2025
Columbus biopharma company secures $18M for diabetic dry eye treatment trials
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
Company News, Funding News
10/22/2025
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
How to Use Milestone Mapping to Chart a Path for Startup Growth
Rev1 News
10/10/2025
How to Use Milestone Mapping to Chart a Path for Startup Growth
71/70 Angels, Interview With Managing Director Melinda Gloriosa
Company News
09/19/2025
71/70 Angels, Interview With Managing Director Melinda Gloriosa
Search for
All Blogs
Topics
Business
Capital
Getting Customers
Getting Funding
Getting Started
Inclusive Entrepreneurship
Market
Press
Product
Rev1 News
Startup Buzz
Team
The Hard Stuff
Uncategorized
VC Trends
1
2
3
…
107
Next »